Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00006358
First received: October 4, 2000
Last updated: July 23, 2008
Last verified: October 2006